Tobacco dependence remains a massive public health challenge in India, where smoking kills millions of people annually. Consequently, medical experts are urging the nation to explore safer nicotine alternatives to complement traditional tobacco-control measures. In particular, this recommendation arises from a recent study in New Zealand. Specifically, daily smoking there fell below 7 percent after integrating regulated lower-risk products. Therefore, Indian healthcare providers must examine these findings to improve local cessation outcomes through structured pulmonology care.
The New Zealand Success Story
Initially, New Zealand implemented conventional demand-reduction measures like graphic warnings and high taxes. However, these traditional strategies only led to gradual declines. The real breakthrough occurred when the government formally recognized regulated vaping products as cessation aids. Consequently, the annual rate of daily smoking decline accelerated from 3.5 percent to 17.9 percent. In fact, this represents a nearly five-fold increase in the pace of reduction. Furthermore, youth smoking continued to decline to historic lows during this period.
Adopting Safer Nicotine Alternatives in India
India currently faces a massive tobacco crisis with over 13 crore smokers and low unassisted quit rates. To address this, Indian pulmonologists suggest distinguishing between the harms of tobacco combustion and nicotine itself. Indeed, the combustion of tobacco generates thousands of toxic chemicals that cause lung cancer and cardiovascular disease. Conversely, pure nicotine replacement therapies present significantly lower risks. Currently, India’s Drugs Technical Advisory Board exempts 2 mg nicotine gum under Schedule K to support cessation. However, experts believe that expanding access to diverse, regulated tools could further accelerate India’s progress, a topic often covered in advanced lung cancer management and cessation training.
Frequently Asked Questions
Q1: What does the Lancet study show about New Zealand’s smoking rates?
The study shows daily smoking fell below 7 percent after the country formally recognized regulated lower-risk nicotine products as cessation aids. Specifically, this policy shift accelerated the annual decline in smoking rates five-fold, from 3.5 percent to 17.9 percent.
Q2: Why do experts differentiate between tobacco combustion and nicotine?
Experts explain that the combustion of tobacco generates thousands of toxic chemicals responsible for lung cancer and heart disease. Meanwhile, nicotine itself does not cause these illnesses, making non-combustible alternatives a much safer option for smokers.
Q3: How does India currently regulate nicotine replacement therapies?
Currently, India’s Drugs Technical Advisory Board exempts 2 mg nicotine gum under Schedule K, allowing over-the-counter access. However, smokers still face limited access to structured tobacco-cessation services and other diverse alternatives across the country, which remains a key focus for professionals pursuing a general practice certification.
References
- Experts highlight need to explore safer nicotine alternatives alongside existingmeasures – ETHealthworld
- Beaglehole R, Bonita R, Youdan B. New Zealand’s accelerating smoking decline: lessons for tobacco harm reduction. The Lancet Regional Health – Western Pacific. 2026.
- Drugs Technical Advisory Board (DTAB), India. Recommendations on Schedule K exemptions for nicotine replacement therapy. 2026.
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.